World's Best Scientists 2026 revealed!
Christie M. Ballantyne

Christie M. Ballantyne

Award Badge
Best Scientists
2025

D-Index & Metrics

Best Scientists

D-Index
168
Citations
125800
World Ranking
941
National Ranking
557

Medicine

D-Index
172
Citations
131565
World Ranking
488
National Ranking
289

Research.com Recognitions

  • 2025 - Research.com Best Scientists Award
  • 2013 - Distinguished Fellowship Award, American College of Cardiology (ACC)
  • 2004 - Fellow of the American Association for the Advancement of Science (AAAS)
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Christie M. Ballantyne is affiliated with Baylor College of Medicine in the United States. Their academic work primarily spans the field of Medicine, with a focus on Cardiology and Cardiovascular Medicine, Surgery, Endocrinology, Diabetes and Metabolism, Economics and Econometrics, and Genetics. Their research emphasizes aspects of cardiovascular health, lipoproteins, lipid metabolism, and associated metabolic conditions.

The main topics covered in Christie Ballantyne's publications include:

  • Lipoproteins and Cardiovascular Health
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Systems, Economic Evaluations, Quality of Life
  • Lipid metabolism and disorders
  • Cancer, Lipids, and Metabolism
  • Cardiovascular Health and Risk Factors
  • Cardiovascular Function and Risk Factors

Christie Ballantyne has contributed numerous articles to respected scientific venues. The most frequent publication outlets for their work are:

  • Circulation
  • Journal of the American College of Cardiology
  • UNC Libraries
  • Journal of clinical lipidology
  • Journal of the American Heart Association

Among recent significant papers where Christie Ballantyne appears as an author or coauthor are:

  • "Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk" (2020, JAMA)
  • "Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality" (2023, New England Journal of Medicine)
  • "The ARIC (Atherosclerosis Risk In Communities) Study" (2021, Journal of the American College of Cardiology)
  • "2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk" (2022, Journal of the American College of Cardiology)
  • "Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study" (2021, European Heart Journal)

Frequent collaborators in Christie Ballantyne's research include:

  • Ron C. Hoogeveen
  • Salim S. Virani
  • Vijay Nambi
  • Josef Coresh
  • Kunihiro Matsushita

Throughout their career, Christie Ballantyne has been recognized with several awards. These include the Distinguished Fellowship Award from the American College of Cardiology (2013), Fellowship of the American Association for the Advancement of Science (2004), and membership in the Association of American Physicians.

Best Publications

  • Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

    Paul M Ridker;Brendan M. Everett;Tom Thuren;Jean G. MacFadyen

  • From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.

    Morteza Naghavi;Peter Libby;Erling Falk;S. Ward Casscells;S. Ward Casscells

  • Biological, clinical and population relevance of 95 loci for blood lipids

    Tanya M. Teslovich;Kiran Musunuru;Albert V. Smith;Andrew C. Edmondson

  • Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.

    Steven E. Nissen;Stephen J. Nicholls;Ilke Sipahi;Peter Libby

  • Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

    Deepak L. Bhatt;P. Gabriel Steg;Michael Miller;Eliot A. Brinton

  • Triglycerides and Cardiovascular Disease A Scientific Statement From the American Heart Association

    Michael Miller;Neil J. Stone;Christie Ballantyne;Vera Bittner

  • Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome

    Gregory G. Schwartz;Anders G. Olsson;Markus Abt;Christie M. Ballantyne

  • Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

    Paul M Ridker;Jean G MacFadyen;Tom Thuren;Brendan M Everett

  • The Metabolic Syndrome and 11-Year Risk of Incident Cardiovascular Disease in the Atherosclerosis Risk in Communities Study

    Ann Marie McNeill;Wayne D. Rosamond;Cynthia J. Girman;Cynthia J. Girman;Sherita Hill Golden

  • Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study.

    Bruce B. Duncan;Bruce B. Duncan;Maria Inês Schmidt;Maria Inês Schmidt;James S. Pankow;Christie M. Ballantyne

  • Effect of Two Intensive Statin Regimens on Progression of Coronary Disease

    Stephen J. Nicholls;Christie M. Ballantyne;Philip J. Barter;M. John Chapman

  • Carotid Intima-Media Thickness and Presence or Absence of Plaque Improves Prediction of Coronary Heart Disease Risk: The ARIC (Atherosclerosis Risk In Communities) Study

    Vijay Nambi;Vijay Nambi;Lloyd Chambless;Aaron R. Folsom;Max He

  • Criteria for Evaluation of Novel Markers of Cardiovascular Risk A Scientific Statement From the American Heart Association

    Mark A. Hlatky;Philip Greenland;Donna K. Arnett;Christie M. Ballantyne

  • Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial

    Stephen J. Nicholls;Stephen J. Nicholls;Rishi Puri;Todd Anderson;Christie M. Ballantyne

  • Lipoprotein-Associated Phospholipase A2, High-Sensitivity C-Reactive Protein, and Risk for Incident Coronary Heart Disease in Middle-Aged Men and Women in the Atherosclerosis Risk in Communities (ARIC) Study

    Christie M. Ballantyne;Ron C. Hoogeveen;Heejung Bang;Josef Coresh

  • Effect of Ezetimibe Coadministered With Atorvastatin in 628 Patients With Primary Hypercholesterolemia: A Prospective, Randomized, Double-Blind Trial

    Christie M. Ballantyne;John Houri;Alberto Notarbartolo;Lorenzo Melani

  • Loss-of-function mutations in APOC3, triglycerides, and coronary disease

    Jacy Crosby;Gina M. Peloso;Gina M. Peloso;Paul L. Auer;David R. Crosslin

  • Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial

    Paul M Ridker;Jean G MacFadyen;Brendan M Everett;Peter Libby

  • A 52-Week Placebo-Controlled Trial of Evolocumab in Hyperlipidemia

    Dirk J. Blom;Tomas Hala;Michael Bolognese;Michael J. Lillestol

  • Effect of Very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis

    Steven E. Nissen;Stephen J. Nicholls;Ilke Sipahi;Peter Libby

Frequent Co-Authors

Salim S. Virani
Salim S. Virani Baylor College of Medicine
Eric Boerwinkle
Eric Boerwinkle The University of Texas Health Science Center at Houston
Elizabeth Selvin
Elizabeth Selvin Johns Hopkins University
Josef Coresh
Josef Coresh New York University
Aaron R. Folsom
Aaron R. Folsom University of Minnesota
Kunihiro Matsushita
Kunihiro Matsushita Johns Hopkins University
Stephen J. Nicholls
Stephen J. Nicholls Monash University
Gerardo Heiss
Gerardo Heiss University of North Carolina at Chapel Hill
James S. Pankow
James S. Pankow University of Minnesota
Harold E. Bays
Harold E. Bays Louisville Metabolic and Atherosclerosis Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Medicine in the USA opens many doors beyond traditional medical degrees. Online health care education is becoming increasingly popular, offering flexibility and career advancement options for busy professionals and recent graduates alike.

Those looking to advance in healthcare management can explore cahme accredited online mha programs. These programs ensure rigorous, industry-recognized training for future administrators and leaders in healthcare settings.

For nurses, there are streamlined pathways for academic progress. If you are a registered nurse seeking bachelor's credentials, you can consider online rn-bsn programs without clinicals, which are ideal for those who need to balance work and study without additional clinical requirements.

Looking to fast-track a doctorate? Prospective nurse leaders might be interested in a 1 year dnp program online for accelerated learning, or select from the easiest online dnp programs to advance clinical and organizational skills with manageable coursework.

These online options help medical and healthcare professionals upskill efficiently while meeting changing industry needs.

Best Scientists Citing Christie M. Ballantyne

Trending Scientists

Recently Published Articles